103 results match your criteria: "centre hospitalier de Dunkerque[Affiliation]"
Qual Life Res
November 2024
Univ. lille, CNRS, UMR 9193, SCALab, Sciences Cognitives et Sciences Affectives, 59000, Lille, France.
Introduction: This study assessed the influence of intrapersonal (one's own emotions) and interpersonal (emotions of others) emotional competence (EC) of informal caregivers on their quality of life (QoL) at the beginning of cancer care.
Methods: Participants completed two questionnaires assessing their intrapersonal and interpersonal EC (S-PEC) as well as their QoL (SF-36) at the beginning of treatments. Multivariate ANCOVA regression analyses were then performed to explore the influence of EC on QoL.
Hematol Oncol
November 2024
Université Paris Cité, Assistante Publique Hôpitaux de Paris, Hôpital Saint-Louis, Service d'Hémato-Oncologie, Paris, France.
Marginal Zone Lymphoma (MZL) comprises three subtypes: extranodal MZL (EMZL), splenic MZL (SMZL) and nodal MZL (NMZL). Since clinical trials have limited representativeness, there is a need for real-world data (RWD) evidence in MZL. Real-world data in Lymphoma and survival in Adults (REALYSA) is a prospective multicentric French cohort of newly diagnosed lymphoma patients.
View Article and Find Full Text PDFKidney Int
September 2024
Department of Nephrology, Centre Hospitalier de Dunkerque, Dunkerque, France.
Rheumatology (Oxford)
July 2024
Département de Néphrologie et Transplantation d'organes, Centre de Référence des maladies rénales rares, Centre Hospitalier Universitaire de Toulouse; French Intensive Care Renal Network, Toulouse, France.
Objectives: Avacopan, a selective C5aR1 inhibitor, recently emerged as a glucocorticoid (GCs) sparing agent in ANCA-associated vasculitis (AAV). We aim to evaluate the tolerance and efficacy of avacopan given outside randomized clinical trials or with severe kidney involvement.
Methods: In this multicentre retrospective study, we reviewed the clinical charts of patients with AAV and contraindication to high dose of GCs who received avacopan 30 mg b.
Appl Psychol Health Well Being
November 2024
Univ. Lille, CNRS, UMR 9193 - SCALab - Sciences Cognitives et Sciences Affectives, Lille, France.
The main objective was to assess the link between emotional competence (EC) and adjustment outcomes such as supportive care needs (SCN) and anxious-depressive symptoms in cancer patients starting chemotherapy. The second objective was to assess the interaction effect between EC and the COVID-19 pandemic (i.e.
View Article and Find Full Text PDFClin Gastroenterol Hepatol
December 2024
Department of Gastroenterology, INFINY Institute, FHU-CURE, INSERM NGERE, Nancy University Hospital, Vandœuvre-lès-Nancy, France.
Background & Aims: The aim of this study was to assess the long-term effectiveness and safety of risankizumab maintenance treatment in a large real-world cohort of patients with Crohn's Disease (CD).
Methods: From May 2021 to August 2023, all consecutive patients with CD treated with risankizumab in 25 GETAID centers have been retrospectively included. The primary endpoint was steroid-free clinical remission (Harvey Bradshaw Index [HBI] <5) at 52 weeks.
Support Care Cancer
April 2024
CHU Besançon, Pôle Pharmacie, 25030, Besançon, France.
Purpose: To ensure the safe use of oral anticancer drugs, oncology pharmacy consultations (OPCs) have been established in France. They are conditioned by the needs, expectations, and involvement of the patients in their care. Thus, it is essential to elicit their preferences.
View Article and Find Full Text PDFSupport Care Cancer
April 2024
Univ. Lille, CNRS, UMR 9193 - SCALab - Sciences Cognitives Et Sciences Affectives, 59000, Lille, France.
Purpose: This cross-sectional study explored the associations between intrapersonal and interpersonal emotional competence (EC) and the unmet supportive care needs (SCN), anxiety, and depression of informal caregivers at the beginning of gastrointestinal or haematological cancer care, i.e. during chemotherapy and within 6 months after diagnosis.
View Article and Find Full Text PDFOrthop Traumatol Surg Res
September 2024
CERS, groupe Ramsay Santé, 83, avenue du Maréchal-de-Lattre-de-Tassigny, 40130 Capbreton, France.
Lancet Rheumatol
September 2023
Department of Rheumatology, Hôpital Saint-Philibert, Université Catholique de Lille, Lomme, France.
Background: Acute calcium pyrophosphate crystal arthritis causes intense joint pain mainly affecting older people. Because guidance and evidence remain scarce, management of this disease relies on expert opinion. We therefore aimed to compare the safety and short-term equivalence of low-dose colchicine with oral prednisone in older patients with acute calcium pyrophosphate crystal arthritis.
View Article and Find Full Text PDFSoins
November 2023
Service de dermatologie, centre hospitalier de Dunkerque, 103 avenue Louis-Herbeaux, 59385 Dunkerque, France; Service de dermatologie, centre de compétence maladies bulleuses auto-immunes, hôpital Claude- Huriez, rue Michel-Polonowski, 59037 Lille, France.
Bullous pemphigoid affects people who are usually very frail, because they are very old and frequently have neurological co-morbidities. Over the past twenty years, therapeutic management has improved thanks to the application of highly potent corticosteroid-based creams, following a well-established regimen, for several months. Well-conducted nursing care is therefore essential not only to cover wounds, but also to treat the disease.
View Article and Find Full Text PDFDermatitis
July 2024
Service de Dermatologie, Centre Hospitalier de Dunkerque, Dunkrik, France, Service de Dermatologie, Centre Hospitalo-Universitaire de Lille, Lille, France.
Blood Adv
January 2024
Department of Clinical Hematology, INSERM U1245 Unit, Centre Henri Becquerel, Rouen, France.
Ther Adv Med Oncol
September 2023
Service de Pneumologie-Oncologie Thoracique, Institut Cœur Poumon, Lille University Hospital, Lille, France.
Background: The optimal duration of immune checkpoint inhibitor (ICI) treatment for patients with advanced non-small cell lung cancer (NSCLC) remains to be determined. Treatment durations in cornerstone phase 3 clinical trials vary between a fixed 2-year duration and pursuit until disease progression. Clinical practices may thus differ according to the attending physician.
View Article and Find Full Text PDFJ Fr Ophtalmol
June 2023
CHRU de Lille, hôpital Claude Huriez, clinique d'ophtalmologie, rue Michel Polonowski, 59037 Lille, France.
Eur J Dermatol
February 2023
CHU Lille, service de dermatologie, F-59000 Lille, France, U1286 Inserm INFINITE Institute for Translational Research in Inflammation, F-59000 Lille, France.
Background: Systemic treatment options for psoriasis are limited for patients with recent neoplasia.
Objectives: We report the real-life use of apremilast (APR) in patients with psoriasis and recent cancer.
Materials & Methods: We conducted a retrospective, multicentre study in five hospitals and among 120 private dermatologists in the north of France from January 2015 to May 2021.
Eur J Oncol Nurs
June 2023
Univ. Lille, CNRS, UMR 9193 - SCALab - Sciences Cognitives et Sciences Affectives, F-59000, Lille, France; Human and Social Sciences Department - Centre Léon Bérard, Lyon, France; Université Claude Bernard Lyon 1, Centre de Recherche en Cancérologie de Lyon - UMR Inserm 1052 - CNRS 5286 - UCBL - CLB, Lyon, France. Electronic address:
Introduction: The existing literature shows a significant impact of cancer on caregivers' quality of life (QoL) and divergent results according to associated factors. To better understand the experience of cancer patients' caregivers, the present study aimed at comparing caregivers' QoL according to cancer care pathway and type of cancer, and at identifying the factors associated with their QoL.
Methods: Caregivers were included in the study either during chemotherapy or follow-up to assess their QoL (CARGOQoL), unmet supportive care needs (SCNS-P&C), and anxiety and depression levels (HADS).
J Fr Ophtalmol
May 2023
CHU de Lille, clinique d'ophtalmologie, hôpital Claude-Huriez, rue Michel-Polonowski, 59037 Lille, France.
Haematologica
December 2023
Maladies du Sang, CHU d'Angers, Angers, France; Federation Hospitalo-Universitaire Grand-Ouest Acute Leukemia, FHU-GOAL; Universite d'Angers, Inserm UMR 1307, CNRS UMR 6075, Nantes Universite, CRCI2NA, F-49000 Angers.
Whereas the prognosis of adult patients with Philadelphia-negative acute lymphoblastic leukemia (ALL) has greatly improved since the advent of pediatric-inspired regimens, the impact of initial central nervous system (CNS) involvement has not been formerly re-evaluated. We report here the outcome of patients with initial CNS involvement included in the pediatric-inspired prospective randomized GRAALL-2005 study. Between 2006 and 2014, 784 adult patients (aged 18-59 years) with newly diagnosed Philadelphia-negative ALL were included, of whom 55 (7%) had CNS involvement.
View Article and Find Full Text PDFJ Nephrol
June 2023
Nephrology Unit, Centre Hospitalier de Dunkerque, Dunkirk, France.
Aliment Pharmacol Ther
February 2023
Department of Gastroenterology and Inserm NGERE U1256, Nancy University Hospital, University of Lorraine, Vandoeuvre-lès-Nancy, France.
Background: Phase III trials have demonstrated the efficacy of risankizumab in moderate-to-severe Crohn's disease (CD), but no real-world data are currently available. We aimed to assess the short-term effectiveness and safety of risankizumab in patients with CD.
Methods: From May 2021 to May 2022, all patients with refractory luminal CD treated with risankizumab in 22 French GETAID centres were retrospectively included.
Nephrol Ther
December 2022
Service de néphrologie, CHU de Lille, Lille, France.
Introduction: Transplantation from controlled donation after circulatory determination of death (cDCD) is a new practice in France. An additional specific consent is required for registration on the cDCD waiting list. The aim of this study is to evaluate the impact of cDCD acceptance on the waiting time for the registered patients on the transplant list.
View Article and Find Full Text PDFRMD Open
November 2022
Rheumatology, Hôpital Bicêtre, Le Kremlin-Bicetre, France.
J Robot Surg
April 2023
Anesthesiology and Pharmacology Department, Centre Hospitalier Dunkerque, Dunkirk, France.
Landmark artery identification in the neurovascular bundle (NVB) is important for nerve-sparing in radical prostatectomy. We aimed to investigate intraoperative angiography using indocyanine green and near-infrared fluorescence (ICG-NIRF) during robot-assisted radical prostatectomy (RARP) to identify the NVB, visualise vascularisation and haemostasis, and preserve erectile function. Our retrospective, unicentric study was performed in consecutive localised prostate cancer RARP patients (stage T1/T2, prostate-specific antigen < 10 ng/ml) who underwent ICG-NIRF angiography in France (2016-2021).
View Article and Find Full Text PDFSupport Care Cancer
November 2022
CNRS, UMR 9193, SCALab, Sciences Cognitives et Sciences Affectives, Université de Lille, Rue du Barreau, BP 60149, 59653, Lille, Villeneuve d'Ascq cedex, France.
Purpose: The objectives of this study were to compare the unmet supportive care needs (SCN) of caregivers and describe the 10 most frequent of them according to various cancer settings: phase of cancer care pathway (i.e., treatment vs.
View Article and Find Full Text PDF